Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Swine Healthcare Market Report by Product, Disease, Route of Administration, Distribution Channel, and Region 2025-2033" report has been added to ResearchAndMarkets.com's offering.
The global swine healthcare market size reached USD 3.2 Billion in 2024. Looking forward, the market is projected to reach USD 5.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.15% during 2025-2033. The increasing dependency on swine products, a considerable rise in commercial swine farming and export activities, and the growing awareness regarding pork-transmitted diseases represent some of the key factors driving the market.
The increasing dependency on swine products among the masses is one of the key factors driving the growth of the market. This can be attributed to a considerable rise in commercial swine farming and export activities across the globe. In line with this, the rising prevalence of numerous diseases, including swine flu, salmonella, mycoplasma hyopneumoniae, and classical swine fever (CSF), is fueling the market. Moreover, the augmenting awareness regarding pork-transmitted diseases is resulting in a higher uptake of swine healthcare products.
Also, favorable initiatives taken by government bodies toward swine health maintenance are fueling the market growth. The continuously growing pork-eating population is propelling the demand for healthy swine livestock, which is further providing an impetus to the market. Besides this, extensive research and development (R&D) activities with an enhanced focus on the development of vaccines to prevent swine flu and swine fever and reduce the effects of swine diseases on humans are contributing to the market.
Additionally, the augmenting incorporation of diagnostic imaging in veterinary hospitals leading to an escalating demand for accessories and diagnostic equipment is contributing to the market. Some of the other factors creating a positive market outlook include the growing adoption rates of vaccines, antibiotics, and surgical treatments for increasing livestock production, a significant rise in the rates of foodborne diseases, rapid globalization, the accelerating demand for organic pork, and considerable growth in the food and beverage (F&B) industry.
Key Market Segmentation:
This report provides an analysis of the key trends in each segment of the global swine healthcare market, along with forecasts at the global, regional, and country level from 2025-2033. The report has categorized the market based on product, disease, route of administration and distribution channel.
Product Insights:
- The report has also provided a detailed breakup and analysis of the swine healthcare market based on the product. This includes diagnostic tests (Enzyme Linked Immuno-Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Agar Gel Immuno-Diffusion (AGID), Polymerase Chain Reaction (PCR), Diagnostic Imaging, and others) and therapeutics (vaccines, parasiticides, anti-infectives, feed additives, and others). According to the report, therapeutics represented the largest segment.
Disease Insights:
- A detailed breakup and analysis of the swine healthcare market based on the disease has also been provided in the report. This includes exudative dermatitis, coccidiosis, respiratory diseases, swine dysentery, porcine parvovirus, and others. According to the report, respiratory diseases accounted for the largest market share.
Route of Administration Insights:
- A detailed breakup and analysis of the swine healthcare market based on the route of administration has also been provided in the report. This includes injectable and oral.
Distribution Channel Insights:
- A detailed breakup and analysis of the swine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals, retail pharmacy and online pharmacy.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for swine healthcare.
Some of the factors driving the North America swine healthcare market included the growing consumption of pork, improving animal healthcare infrastructure and the growing consciousness regarding pork-transmitted diseases.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global swine healthcare market. Detailed profiles of all major companies have also been provided.
Some of the companies covered include:
- Boehringer Ingelheim
- Ceva Animal Health
- Elanco
- IDEXX Laboratories
- Innovative Diagnostic
- Merck & Co.
- Phibro Animal Health Corporation
- Vetoquinol
- Virbac
- Zoetis
Key Questions Answered in This Report
- How big is the global swine healthcare market?
- What is the expected growth rate of the global swine healthcare market during 2025-2033?
- What are the key factors driving the global swine healthcare market?
- What has been the impact of COVID-19 on the global swine healthcare market?
- What is the breakup of the global swine healthcare market based on the product?
- What is the breakup of the global swine healthcare market based on the disease?
- What are the key regions in the global swine healthcare market?
- Who are the key players/companies in the global swine healthcare market?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Swine Healthcare Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Diagnostic Tests
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Enzyme Linked Immuno-Sorbent Assay (ELISA)
6.1.2.2 Rapid Immuno Migration (RIM)
6.1.2.3 Agar Gel Immuno-Diffusion (AGID)
6.1.2.4 Polymerase Chain Reaction (PCR)
6.1.2.5 Diagnostic Imaging
6.1.2.6 Others
6.1.3 Market Forecast
6.2 Therapeutics
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Vaccines
6.2.2.2 Parasiticides
6.2.2.3 Anti-infectives
6.2.2.4 Feed Additives
6.2.2.5 Others
6.2.3 Market Forecast
7 Market Breakup by Disease
7.1 Exudative Dermatitis
7.2 Coccidiosis
7.3 Respiratory Diseases
7.4 Swine Dysentery
7.5 Porcine Parvovirus
7.6 Others
8 Market Breakup by Route of Administration
8.1 Injectable
8.2 Oral
9 Market Breakup by Distribution Channel
9.1 Veterinary Hospitals
9.2 Retail Pharmacy
9.3 Online Pharmacy
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Asia-Pacific
10.2.1 China
10.2.2 Japan
10.2.3 India
10.2.4 South Korea
10.2.5 Australia
10.2.6 Indonesia
10.2.7 Others
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 United Kingdom
10.3.4 Italy
10.3.5 Spain
10.3.6 Russia
10.3.7 Others
10.4 Latin America
10.4.1 Brazil
10.4.2 Mexico
10.4.3 Others
10.5 Middle East and Africa
11 Drivers, Restraints, and Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- Boehringer Ingelheim International
- Ceva Animal Health Inc.
- Elanco
- IDEXX Laboratories Inc.
- Innovative Diagnostic
- Merck & Co. Inc.
- Phibro Animal Health Corporation
- Vetoquinol
- Virbac Corporation
- Zoetis
For more information about this report visit https://www.researchandmarkets.com/r/7g1ld3
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
